Prolia
April 7, 2012 by Vivian Goldschmidt, MA
Prolia Pros And Cons
At only 2 years out from FDA approval, Prolia (generic name, denosumab) is still considered a new treatment – so the pros and cons are still being weighed and considered … Continue Reading →
July 14, 2010 by Vivian Goldschmidt, MA
Prolia (Denosumab): My Review
This past June 1st, the FDA approved Prolia ™ (denosumab), a brand new twice-yearly injectable osteoporosis drug by Amgen. The first drug of its kind, Prolia was designed to treat … Continue Reading →